Conditioning with MEL200 or BUMEL produced similar outcomes at 7 years.
Researchers sought to determine whether tisagenlecleucel was effective would be effective in infant patients with B-ALL
Researchers sought to determine patterns in coagulation parameters linked to cytokine-release syndrome in patients receiving CAR-T therapy.
Researchers sought to determine whether adding brentuximab vedotin to AVD would improve survival in patients with stage III or IV Hodgkin lymphoma.
Use of PCD CT images with convolutional neural network denoising improves viewing of pathologic abnormalities, detects lytic lesions.